Autologous Organoid-T Cell Co-Culture Platform for Modeling of Immune-Mediated Drug-Induced Liver Injury.
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Nov 2026 · 1 min read
In brief
In brief
This study presents an autologous co-culture system combining iPSC-derived liver organoids with patient-matched T cells to model immune-mediated drug-induced liver injury. The platform enables investigation of idiosyncratic hepatotoxicity mechanisms that conventional models cannot capture, offering a personalized approach to studying adaptive immune responses in liver disease.
Written by the GCMD Library team from the article.
Statements in this article
Conventional hepatotoxicity models lack the components required to capture patient-specific, T cell-mediated injury.
A scalable and matrix-free human liver organoid platform incorporating autologous T cells can model immune-mediated drug-induced liver injury.